Navigation Links
PowerVision Appoints Ophthalmology Thought Leader Douglas D. Koch, M.D. to its Scientific Advisory Board

BELMONT, Calif., July 21, 2014 /PRNewswire/ -- PowerVision, Inc., a medical device company developing the world's first fluid-based accommodating intraocular lens, today announced that Douglas D. Koch, M.D., the Allen, Mosbacher, and Law Chair of Ophthalmology, and Professor of Ophthalmology, at Baylor College of Medicine has joined the company's Scientific Advisory Board.

As a recipient of several prestigious honors, including the American Academy of Ophthalmology Lifetime Achievement award, Koch will join the distinguished group who will guide PowerVision's team in the development of the FluidVision™ lens, the first fluid based accommodating intraocular lens designed to permanently restore clear vision at all distances for patients with cataracts and presbyopia, as the company works to secure its European approval, launch its pivotal study in the U.S. and prepare for a U.S. launch. The panel provides guidance on all aspects of product development, including surgical technique, design of the delivery system, clinical trial design and market positioning.

"I believe the FluidVision lens's distinctive shape-shifting and accommodative capabilities could be life-changing," said Koch.  "Many people still carry reading glasses post-surgery, since current procedures have yet to provide adequate visual clarity at all distances. The FluidVision lens addresses the other half of vision impairment problems, and will alleviate a source of frustration for my future patients. I'm excited and extremely happy to play a role in the development of a truly groundbreaking technology that can revolutionize the capabilities of intraocular lenses."

In addition to Prof. Koch, PowerVision's Scientific Advisory Board currently includes:

  • David Chang, M.D., an internationally acclaimed cataract surgeon with a private practice in Los Altos, Calif.
  • Ralph Chu, M.D., an expert in cataract and refractive surgery and Medical Director at Chu Vision Institute in Bloomington, MN
  • Adrian Glasser, Ph.D., Professor of Optometry and Vision Sciences and Biomedical Engineering at University of Houston's College of Optometry and one of the world's experts in the physiology of accommodation.
  • Terry Kim, M.D., Professor of Ophthalmology at Duke University's Eye Center in Durham, NC and a leading specialist in cataract surgery, corneal transplantation, and refractive surgery
  • Steve Lane, M.D., Clinical Professor of Ophthalmology at University of Minnesota and an expert in cataract and refractive surgery
  • Sam Masket, M.D., former ASCRS president and an expert ophthalmic surgeon at Advanced Vision Care in Los Angeles, CA
  • Louis (Skip) Nichamin, M.D., a thought leader in cataract and refractive surgery
  • Liliana Werner, M.D., Ph.D., Associate Professor of Ophthalmology at University of Utah's Moran Eye Center in Salt Lake City, UT

In the U.S. alone, there are currently three million cataract patients every year who receive traditional intraocular lens implants. These implants are thin pieces of plastic that allow patients to see far distances, but typically do not eliminate the need for additional corrective lenses. FluidVision lenses provide True Accommodation™ by simulating a healthy eye's ability to change shape and adjust focus. The lens is implanted with the same surgical techniques used for traditional intraocular lens procedures.

"We are honored to welcome Dr. Koch and his wealth of knowledge to the board," said Mr. Barry Cheskin, PowerVision's President & CEO and Co-Founder. "There is a large market of vision-impaired patients who are looking for an all-purpose solution. Koch and the other members' experience will be integral in helping FluidVision address this unmet need, as we are in the process of completing our CE Mark trial and preparing for our US study. With the additional expertise of PowerVision's world-class Scientific Advisory Board, we believe this accommodative lens could have an impact on vision care beyond what we've seen anywhere else."

According to PowerVision's most recent pilot study data, which was presented at the American Society of Cataract and Refractive Surgery (ASCRS) Annual Symposium in April, patients who received the FluidVision lens in one eye during cataract surgery had impressive results of 20/33, 20/25 and 20/20 respectively for near, intermediate, and distance vision.

By the end of 2014, PowerVision will have completed patient enrollment for its CE mark study, which will lead up to a subsequent U.S. study in 2015.

About Presbyopia and Cataracts

Presbyopia is a vision condition in which the crystalline lens of the eye loses its flexibility, which makes it difficult to focus on close objects. Presbyopia may seem to occur suddenly, but the actual loss of flexibility takes place over a number of years. Presbyopia usually becomes noticeable in the early to mid-40s. Presbyopia is a natural part of the aging process of the eye. It is not a disease, and it cannot be prevented.* The potential market for presbyopia treatments exceeds $5 billion annually in the U.S alone.

A cataract is a cloudy or opaque area in the normally clear lens of the eye. Depending upon its size and location, it can interfere with normal vision. Most cataracts develop in people over age 55, but they occasionally occur in infants and young children. The treatment of cataracts is based on the level of visual impairment they cause. When a cataract progresses to the point that it affects a person's ability to do normal everyday tasks, surgery may be needed. Cataract surgery involves removing the diseased lens and replacing it with an artificial lens. Cataracts affect millions of Americans and Medicare currently spends $3.4 billion to treat these cataracts annually.

About PowerVision

PowerVision, Inc. is a private company focused on developing a novel accommodating intraocular lens, which, it believes, will be the first to restore True Accommodation™. Its innovative FluidVision accommodating intraocular lens (IOL) aims to restore the vision of youth to older individuals affected by presbyopia and/or cataracts. PowerVision's mission is to provide a family of fluid-based lens implants that meet the clinical and lifestyle needs caused by these conditions, and develop the most significant innovation in vision correction surgery since the introduction of the intraocular lens. The FluidVision lens is an investigational device that is not available for sale and is available for use only by the investigators participating in the multi-center clinical study.

*American Optometric Association:

Barry Cheskin
President & CEO, Co-Founder
Phone: 650-620-9948 x212

Media Contact:
Hollister Hovey
Lazar Partners Ltd.
Phone: 646-871-8482

SOURCE PowerVision, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Nonin Medical Appoints Ash Keswani Vice President of Marketing
2. InspireMD Appoints Dr. James Barry as Chief Operating Officer
3. Xencor Appoints Kurt Gustafson to Board of Directors; Promotes John Desjarlais to Chief Scientific Officer
4. BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors
5. Tegra Medical Appoints New Chief Executive Officer
6. Meditope Biosciences Appoints Prominent Scientific Advisory Board
7. Actavis Appoints Industry Veterans to Lead U.S. Specialty Brands Business Units
8. Analyte Health Appoints Lawrence Leisure to its Advisory Board
9. ShangPharma Appoints Pharmaceutical Executive Dr. Mitchell Reff Chief Biologics Officer
10. Cardica Appoints Industry Veteran Liam Burns As Vice President, Sales And Marketing
11. PhaseRx Appoints Michael Houston, Ph.D., Vice President, Therapeutics Development
Post Your Comments:
(Date:10/9/2015)... 2015  Eli Lilly and Company (NYSE: LLY ... worldwide rights to Locemia,s intranasal glucagon, a potential treatment ... insulin. Intranasal glucagon, which is currently in Phase III ... treatment for severe hypoglycemia. --> ... glucagon nasal powder formulation that is delivered in an ...
(Date:10/9/2015)... 9, 2015 Regardless of your function ... communications is perpetually evolving. Due to the ever-changing ... continuously adjust their business-to-business (B2B) communication strategies and ... difficult, but also critical as a way to ... --> --> A ...
(Date:10/9/2015)... , Oct. 9, 2015 Regulatory affairs groups within ... --> --> These specialized groups are ... plethora of global regulations pertaining to the development and marketing ... regulatory groups largely rely on their own internal effectiveness and ... --> --> ...
Breaking Medicine Technology:
... LAKE FOREST, Ill., July 27, 2011 Hospira, Inc. ... pharmaceutical and medication delivery company, today reported results for ... for the quarter were $1.1 billion, and adjusted* diluted ... specified items as described later in this press release ...
... MOUNT LAUREL, N.J., July 27, 2011 ImpactRx, ... on physician prescribing behavior, announces the rollout of ... by the Company,s iPhone-enabled longitudinal physician panels. ... Company,s iPhone-based syndicated research model, POP (Point-of-Promotion/Point-of-Prescribing) surveys ...
Cached Medicine Technology:
(Date:10/10/2015)... ... October 10, 2015 , ... With the winter season coming close, the need for additional ... Cozy Products is familiar with the problem and discusses the issue. , “Don’t use ... inside of the chicken coop in the winter, utilize a safe heat source such as ...
(Date:10/10/2015)... ... ... walk with crutches for the rest of my life," said an inventor from San Diego, ... give me more independence and freedom would be amazing. This inspired me to invent a ... STRAP IN to enable an individual to walk with crutches without having to use his ...
(Date:10/10/2015)... ... October 10, 2015 , ... The sixth annual cost ... the growth of cybercrime costs for US companies. The New York Times broke down ... With averages showing increases hovering around 20% among the companies surveyed, it only proves ...
(Date:10/10/2015)... (PRWEB) , ... October 10, 2015 , ... The Bank ... Speedway in Concord, NC. Saturday, October 10th, defending race winner, Kevin Harvick, ... Logano, Matt Kenseth, Dale Earnhardt Jr., and all of the stars of the NASCAR ...
(Date:10/10/2015)... ... October 10, 2015 , ... Story Chaser is ... works by reading various classics and inspiring stories and as words drop down and ... The animations are extremely aesthetic and can be interacted with, making it a more ...
Breaking Medicine News(10 mins):
... ON, June 22 /PRNewswire-FirstCall/ - Bioniche Life Sciences ... biopharmaceutical company, today provided an update on its ... that it was experiencing delays in concluding a ... Complex (MCC), formulated as Urocidin(TM), for the intravesical ...
... , BOSTON, June 22 Bringing the next ... Informatics, a leading eClinical solutions provider and subsidiary ... ), today announced that it has launched its ... and access to data across multiple technologies throughout ...
... SINGAPORE, June 22 /PRNewswire-Asia/ -- 11th of June ... as well as the Optical industry,in Korea. Recognizing the ... performance of the optical market in Korea, the Korean ... between both,organizations. This partnership will add and build on ...
... ... its 52nd center in South Elgin. , ... Oak Brook, IL (Vocus) June 22, 2009 -- AthletiCo, an Illinois-based leader in ... South Elgin center is located at 722 N. McLean Blvd in South Elgin. AthletiCo ...
... With the outbreak of H1N1 influenza in several countries, people ... effectively prevent the disease from spreading. The discussion for a ... topic around the world. In fact, the vaccine market has ... and globally for quite some time now. , , ...
... that Caucasians are much more likely than people in other ... cancer called Ewing,s sarcoma. In addition, among Caucasians with this ... in the August 1, 2009 issue of CANCER , ... indicates that examining the gender and racial differences related to ...
Cached Medicine News:
Sinskey tying forceps, straight, fine, 7 mm tying platforms....
Curved, very delicate, smooth jaws with platforms., ,Straight, very delicate, smooth jaws with platforms....
Fine tying forceps, curved tips, wide handle....
Shepard tying forceps, round curved platform 8 mm, 8.5 cm....
Medicine Products: